Martin F. Fromm - Concepedia

Author

Martin F. Fromm

Friedrich-Alexander-Universität Erlangen-Nürnberg ORCID

Also Known As

Fromm, M., Fromm, Martin, J. Berger, M F Fromm, M FROMM, M Fromm, M. F. Fromm, M. Fromm, M.F. Fromm, MARTIN F. FROMM

300

Publications

20.5K

Citations

H-Index

153

Concepts

All Affiliations

Friedrich-Alexander-Universität Erlangen-Nürnberg Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology University of Tübingen Universitätsklinikum Erlangen Robert Bosch Hospital

About

Martin F. Fromm is an author at Friedrich-Alexander-Universität Erlangen-Nürnberg specializing in medicine, pharmacology, and biochemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	36	59	5.6K
2	Natural Sciences	11	11	366
3	Health Sciences	7	7	711
4	Engineering	4	4	212
5	Public Health	2	2	358

Martin F. Fromm

149

Publications

14.7K

Citations

H-Index

Page 1

	Year	Citations
The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors. Richard B. Kim, Martin F. Fromm, Christoph Wandel, Journal of Clinical Investigation Oral BioavailabilityImmunologyPharmacotherapyAntiviral DrugMdr1a Gene	1998	1.1K
OATP and P-Glycoprotein Transporters Mediate the Cellular Uptake and Excretion of Fexofenadine Mirjana Cvetković, Brenda F. Leake, Martin F. Fromm, Drug Metabolism and Disposition	1999	593
Cytochrome P450 2C19 681G>A Polymorphism and High On-Clopidogrel Platelet Reactivity Associated With Adverse 1-Year Clinical Outcome of Elective Percutaneous Coronary Intervention With Drug-Eluting or Bare-Metal Stents Dietmar Trenk, Willibald Hochholzer, Martin F. Fromm, Journal of the American College of Cardiology ThrombosisPercutaneous Coronary InterventionCardiovascular DiseaseBlood PlateletMyocardial Infarction	2008	543
Piperine, a Major Constituent of Black Pepper, Inhibits Human P-glycoprotein and CYP3A4 Rajinder Bhardwaj, Hartmut Glaeser, Laurent Becquemont, Journal of Pharmacology and Experimental Therapeutics	2002	516
Interrelationship Between Substrates and Inhibitors of Human CYP3A and P-Glycoprotein Richard B. Kirn, Christoph Wandel, Brenda F. Leake, Pharmaceutical Research	1999	459
High plasma pravastatin concentrations are associated with single nucleotide polymorphisms and haplotypes of organic anion transporting polypeptide-C (OATP-C, SLCO1B1) Mikko Niemi, Elke Schaeffeler, Thomas Lang, Pharmacogenetics	2004	416
ABCG2 Polymorphism Markedly Affects the Pharmacokinetics of Atorvastatin and Rosuvastatin Jenni E. Keskitalo, Oliver Zolk, Martin F. Fromm, Clinical Pharmacology & Therapeutics	2009	413
Inhibition of P-Glycoprotein–Mediated Drug Transport Martin F. Fromm, Richard B. Kim, C. Michael Stein, Circulation	1999	398
The C3435T mutation in the human MDR1 gene is associated with altered efflux of the P-glycoprotein substrate rhodamine 123 from CD56+ natural killer cells Monika Hitzl, Siegfried Drescher, Heiko van der Kuip, Pharmacogenetics	2001	374
Association between the C3435T MDR1 gene polymorphism and susceptibility for ulcerative colitis Matthias Schwab, Elke Schaeffeler, Claudia Marx, Gastroenterology InflammationMedicineImmunologyGenetic EpidemiologyPathology	2003	321

Page 1